Quantitative RT-PCR Detection of Colorectal Tumor Cells in Peripheral Blood-A Systematic Review

Journal of Surgical Research

Volumn 150, Issue 1, 2008, Pages 144-152

  Sergeant, Gregory ^a   Penninckx, Freddy ^a   Topal, Baki ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

colorectal neoplasms C04.588.274.476.411.307 ; neoplasm circulating cells C23.550.727.650.645 ; quantitative RT PCR; real time RT PCR; reverse transcription polymerase chain reaction E05.393.620.500.725

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CANCER SURVIVAL; COLORECTAL TUMOR; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BLOOD SPECIMEN COLLECTION; COLORECTAL NEOPLASMS; HUMANS; IMMUNOMAGNETIC SEPARATION; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53249084205     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.02.012     Document Type: Article

References (73)

1. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev 4 (2004) 448
2. Cohen A.M., Kelsen D., Saltz L., et al. Adjuvant therapy for colorectal cancer. Curr Problems Surg 34 (1997) 601
3. Ratto C., Sofo L., Ippoliti M., et al. Prognostic factors in colorectal cancer. Literature review for clinical application. Dis Colon Rectum 41 (1998) 1033
4. Weitz J. Does intraoperative tumor cell dissemination matter?. J Am Coll Surg 205 (2007) S31
5. White H., Griffiths J.D., and Salisbury A.J. Circulating malignant cells and fibrinolysis during resection of colorectal cancer. Proc R Soc Med 69 (1976) 467
6. Roberts S., Jonasson O., Long L., et al. Clinical significance of cancer cells in the circulating blood: Two to five year survival. Ann Surg 154 (1961) 362
7. Engell H.C. Cancer cells in the blood: A five- to nine-year follow-up study. Ann Surg 149 (1959) 457
8. Pool E.H., and Dunlop G.R. Cancer cells in the bloodstream. Am J Surg 21 (1934) 99
9. Leather A.J., Gallegos N.C., Kocjan G., et al. Detection and enumeration of circulating tumor cells in colorectal cancer. Br J Surg 80 (1993) 777
10. Tsavellas G., Huang A., Mc Cullough T., et al. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. Clin Exp Metast 19 (2002) 495
11. Smith B., Selby P., Southgate J., et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338 (1991) 1227
12. Jonas S., Windeatt S., O-Boateng A., et al. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 39 (1996) 717
13. Wyld D.K., Selby P., Perren T.J., et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79 (1998) 288
14. Hardingham J.E., Kotasek D., Sage R.E., et al. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med (Cambridge, MA) 1 (1995) 789
15. Wong L.S., Cantrill J.E., Odogwu S., et al. Detection of circulating tumor cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique. Br J Surg 84 (1997) 834
16. Wharton R.Q., Jonas S.K., Glover C., et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5 (1999) 4158
17. Tsavellas G., Patel H., and Allen-Mersh T.G. Detection and clinical significance of occult tumor cells in colorectal cancer. British J Surg 88 (2001) 1307
18. Bilchik A.J., Saha S., Wiese D., et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter Phase II trial. J Clin Oncol 19 (2001) 1128
19. Yamaguchi K., Takagi Y., Aoki S., et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232 (2000) 58
20. Allen-Mersh T.G., McCullough T.K., Patel H., et al. Role of circulating tumor cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 94 (2007) 96
21. Koch M., Kienle P., Kastrati D., et al. Prognostic impact of hematogenous tumor cell dissemination in patients with Stage II colorectal cancer. Int J Cancer 118 (2006) 3072
22. Taniguchi T., Makino M., Suzuki K., et al. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89 (2000) 970
23. Hardingham J.E., Hewett P.J., Sage R.E., et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 89 (2000) 8
24. Funaki N.O., Tanaka J., Ohshio G., et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer 77 (1998) 1327
25. Mori M., Mimori K., Ueo H., et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 16 (1998) 128
26. Soeth E., Vogel I., Roder C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57 (1997) 3106
27. Mocellin S., Rossi C.R., Pilati P., et al. Quantitative real-time PCR: A powerful ally in cancer research. Trends Mol Med 9 (2003) 189
28. Davis E.G., Chao C., and McMasters K.M. Polymerase chain reaction in the staging of solid tumors. Cancer J (Sudbury, MA) 8 (2002) 135
29. Schuster R., Max N., Mann B., et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 108 (2004) 219
30. Chalmers T.C., Berrier J., Sacks H.S., et al. Meta-analysis of clinical trials as a scientific discipline. II. Replicate variability and comparison of studies that agree and disagree. Stat Med 6 (1987) 733
31. Chalmers T.C. Problems induced by meta-analyses. Stat Med 10 (1991) 971 Discussion 979
32. Ito S., Nakanishi H., Hirai T., et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 183 (2002) 195
33. Bustin S.A., Gyselman V.G., Williams N.S., et al. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 79 (1999) 1813
34. Chen W.S., Chung M.Y., Liu J.H., et al. Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery. World J Surg 28 (2004) 552
35. Iinuma H., Okinaga K., Egami H., et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 28 (2006) 297
36. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236 (2002) 768 Discussion 775
37. Miura M., Ichikawa Y., Tanaka K., et al. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Anticancer Res 23 (2003) 1271
38. Dandachi N., Balic M., Stanzer S., et al. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients. J Mol Diagn 7 (2005) 631
39. Friederichs J., Gertler R., Rosenberg R., et al. Correlation of CK-20-positive cells in peripheral venous blood with serum CEA Levels in patients with colorectal carcinoma. World J Surg 31 (2007) 2329
40. Guo J., Xiao B., Jin Z., et al. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymerase chain reaction. J Gastroenterol Hepatol 20 (2005) 1279
41. Giribaldi G., Procida S., Ulliers D., et al. Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method. J Mol Diagn 8 (2006) 105
42. Xu D., Li X.F., Zheng S., et al. Quantitative real-time RT-PCR detection for CEA, CK20, and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci 7 (2006) 445
43. Friederichs J., Gertler R., Rosenberg R., et al. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg 29 (2005) 422
44. Paterlini-Brechot P., and Benali N.L. Circulating tumor cells (CTC) detection: Clinical impact and future directions. Cancer Lett 253 (2007) 180
45. Vlems F.A., Diepstra J.H.S., Cornelissen I.M.H.A., et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumor cells in blood and bone marrow of patients with colorectal cancer: Expression in controls and down-regulation in tumor tissue. J Clin Pathol Mol Pathol 55 (2002) 156
46. Goeminne J., Guillaume T., and Symann M. Pitfalls in the detection of disseminated nonhematological tumor cells. Ann Oncol 11 (2000) 785
47. Wang J.Y., Wu C.H., Lu C.Y., et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: Significance of the prediction of postoperative metastasis. World J Surg 30 (2006) 1007
48. Gan L., Lee I., Smith R., et al. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257 (2000) 119
49. Anisowicz A., Sotiropoulou G., Stenman G., et al. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med (Cambridge, MA) 2 (1996) 624
50. Birbe R., Palazzo J.P., Walters R., et al. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Hum Pathol 36 (2005) 170
51. Carrithers S.L., Barber M.T., Biswas S., et al. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci USA 93 (1996) 14827
52. Waldman S.A., Barber M., Pearlman J., et al. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro. Cancer Epidemiol Biomarkers Prev 7 (1998) 505
53. Bhatavdekar J.M., Patel D.D., Chikhlikar P.R., et al. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis Colon Rectum 44 (2001) 523
54. Moll I., and Moll R. Early development of human Merkel cells. Exp Dermatol 1 (1992) 180
55. Moll R., Lowe A., Laufer J., et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140 (1992) 427
56. Bustin S.A., Gyselman V.G., Siddiqi S., et al. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. Int J Surg Invest 2 (2000) 49
57. Van Eekelen J.A., Shammas F.V., Wee L., et al. Quantitative analysis of cytokeratin 20 gene expression using RT-PCR and capillary electrophoresis with fluorescent DNA detection. Clin Biochem 33 (2000) 457
58. Crisan D., Ruark D.S., Decker D.A., et al. Detection of circulating epithelial cells after surgery for benign breast disease. Mol Diagnost 5 (2000) 33
59. Lobodasch K., Frohlich F., Rengsberger M., et al. Quantification of circulating tumor cells for the monitoring of adjuvant therapy in breast cancer: An increase in cell number at completion of therapy is a predictor of early relapse. Breast (Edinburgh, Scotland) 16 (2007) 211
60. Weiss L., and Dimitrov D.S. A fluid mechanical analysis of velocity, adhesion, and destruction of cancer cells in capillaries during metastasis. Cell Biophys 6 (1984) 9
61. Mocellin S., Keilholz U., Rossi C.R., et al. Circulating tumor cells: The "leukemic phase" of solid cancers. Trends Mol Med 12 (2006) 130
62. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. JCB 172 (2006) 973
63. Klein C.A., Blankenstein T.J., Schmidt-Kittler O., et al. Genetic heterogeneity of single disseminated tumor cells in minimal residual cancer. Lancet 360 (2002) 683
64. Smirnov D.A., Zweitzig D.R., Foulk B.W., et al. Global gene expression profiling of circulating tumor cells. Cancer Res 65 (2005) 4993
65. Huang E.H., Heidt D.G., Li C.W., et al. Cancer stem cells: A new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141 (2007) 415
66. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105
67. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumor initiating cells. Nature 432 (2004) 396
68. Al-Hajj M., Wicha M.S., Benito-Hernandez A., et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 (2003) 3983
69. Patrawala L., Calhoun T., Schneider-Broussard R., et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65 (2005) 6207
70. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111
71. O'Brien C.A., Pollett A., Gallinger S., et al. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445 (2007) 106
72. Li C., Heidt D.G., Dalerba P., et al. Identification of pancreatic cancer stem cells. Cancer Res 67 (2007) 1030
73. Hermann P., Huber S., Herrler T., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer cell. Stem Cell 1 (2007) 313